Show Menu

Lactate dehydr­ogenase

lactate + NAD+ --> pyruvate + NADH + H+
H-form: aerobic , heart L-->P
M-form: anaerobic , muscle­/liver P-->L
Reagents: Lactat­e,N­AD+­,Ox­idized PMS, Oxidized NBT
Specific Activity stain
LDH-1: pyruvate inhibition
LDH-1/2: 2-hydr­oxy­but­yrate as S
LDH-4/5: greater heat stability

Creatine Kinase

Creatine + ATP <--> creatine phosphate + ADP + H+
Cardiac: MM+ MB (Myoca­rdial infarc­tion)
Skeletal: MM
Brain: BB

Chymosin (Rennin)

Aspartic protease
Cleave single peptide bond,
release acidic C-terminal peptide
Ca induced aggreg­ation of modified casein micell­e--> precip­itate as curd

Affinity label

Specific & Irreve­rsible inhibitor
Specif­icity group & reactive group
resembles substrate
TPCK on His-57 of Chymot­rypsin

Determ­ination of enzyme activity

NAD+ : absorbance change at 340nm
FAD: absorbance change at 440 nm X


Follow INITIAL rate, rate drops
1. substrate depletion
2. reverse reaction
3. product inhibition
4. enzyme stability



1. [S] control, M-M vs Cooper­ativity
2. Allosteric effect
3. [S]cycle, 2-way, 6-Phos­pho­fru­cto­kinase & Fructose bispho­sph­atase
4. Zymogen activation
5. Covalent modifi­cation (phosp­hor­yla­tio­n,a­den­yly­lat­ion­,my­ris­toy­lat­ion­,AD­P-r­ibo­syl­ati­on,­met­hyl­ati­on,­ace­tyl­ati­on,­ubi­qui­tin­ation)
6. Enzyme cascade
7. Cascade amp
8. Enzyme induct­ion­/de­gra­dation

Modifi­cation of amino acids

Active site residues more suscep­tible
Ser-195 on chymot­rypsin by DIPF -->­Act­ivity
Modify 1st with [S]/[I] to protect active site, then modify again in absence
ADH inacti­vated by iodoac­etate more than iodoac­etamide
2AA involved: pKa >2 units apart:Good
Close-­-> tVmax never achieved

Lite Beer

Barley­:α-­amylase cannot break down α-1,6 bond + dextrin --> Yeast
Glucoa­mylase from Asperg­illus niger: break α-1,6 bond, less dextrin


L-phen­yla­lanine + N-prot­ected L-aspa­rtate
N: benzyl­oxy­car­bonyl


1. Strain­/Di­sto­rtion: entropy reduction
2. Acid-Base : carbonic anhydrase
3. Covalent catalysis: serine protease
4. Lower Ea: Zn&Arg127 in carbox­ype­ptidase A stabilize TS
Histidine can be both e- donor/­acc­eptor
TS analogue: pyrrol­e-2­-ca­rbo­xylate on proline racemase as inhibitor
Abzyme: mimic Ferroc­hel­atase


RNA less versatile (4 building blocks AUCG)
unable to form large non-polar region
nucleic acid preferred as substrate
RNA suscep­tible to hydrolysis

Organic Cofactors

Catalytic cofactor: e.g. TPP/FAD
Stoich­iom­etric cofactor: cosubs­trate


Glutamate decarb­oxylase
CO2 : trap gas in alkali
Monoamine oxidase
R-CHO:­ext­racted by ether after acidif­ication (acidified R-NH2 will remain in aq phase)
COOH: ion exchange, importance of label position

Scinti­llation Proximity Assay

Radiol­igand stimulate bead to emit light, when in close proximity
High affinity capture system: biotin­ylated substrate & strept­avi­din­-coated beads
NO separation needed. S or P bind to bead

Compet­itive inhibitor

Same site, mutually exclusive
Vmax unchanged Km increased

Non-co­mpe­titive inhibitor

ESI present, Km unchanged, Vmax decrease,
equal Ki,same % inhib.

Pre-steady state kinetics

E+S--> ES(flu­ror­esc­ence)
Stopped flow technique, follow time course of fluore­scence change

Irreve­rsible inhibitor

Diisop­ropyl phosph­ofl­uor­idate (DIPF) modifies serine on AchE

Hill Coeffi­cient

Important: Choice of [S]
Cooper­ati­vity: Same site&ligand


Active site Ser195­,Hi­s57­&A­sp102 form charge relay system­--> high reactivity of Ser195
Selective for carboxyl side of aromatic or large hydrop­hobic residu­e(Met)
Biphasic kinetics:
1. Burst phase: covalent complex
2. SS Phase: hydrol­ysis+ recovery
Double displa­cement, p-nitr­oph­enolate


inactive form
partic­ipate in reacti­on(­lewis acid)
Zn in carbonic anhydrase
stabilize transition state
Zn in carbox­ype­ptidase A
Metal activated enzyme
maintain active confor­mation
K+ in pyruvate kinase
Metal activated enzyme
form substrate complex bridge
Mg in kinase
Prosthetic group
tightly bound
NH2 on pyridoxal phosphate of aspartate transa­minase
loosly bound
convert to product after Rx

Coenzyme analogue as drug

Analogue of
enzyme inhibited
MOA & Use
dihydr­opt­eroate synthase
folic acid synthe­sis,Abx
dihydr­ofolate reductase
THF synthe­sis­,ch­ildhood leukemia


Uncomp­etitive inhib.

S binding to E--> expose site for I binding
both Km Vmax decrease to same extent, ESI present, same slope

Mixed inhibition

Binding affini­ty(Ki) not the same
Vmax decrease, Km can in/dec­rease

Suicide substrate

P irreve­rsibly bind to E
Deprenyl on MAO on Flavin prosthetic group

Substrate inhibition

High [S] favour ESS(no­npr­odu­ctive binding)
e.g. succinate dehydr­ogenase (select points for drawing)

Single displa­cement Rx

Random sequential
creatine kinase
Compulsory order
ADH(NAD+ bind 1st)
Ternary complex present

Double displa­cement Rx (Ping-­Pong)

aspartate transa­minase
aspartate+ α-keto­glu­tarate -->­oxa­loa­cetate+ glutamate (NH2 displaced)

Isotope exchange

Occurs only in double displa­cement;
exception: maltose phosph­orylase
isotope from 1st P back to 1st S in absence of 2nd S e.g. sucrose phosph­orylase
Glu-Fru + Fru* <--> Glu-Fru* + Fru

Diff. subunits of multimeric enzyme

Catalytic & Regulatory
Aspartate transc­arb­amo­yla­se(­ATCase)
2nd unit modify specif­icity
Lactose synthase
2 diff. cat. units
tryptophan syntha­se(­α2β2)
Tunnel connect active sites


hydrolyze glycosidic bond bet C-1 of NAM and C-4 of NAG, Non-id­entical site
Site of cleavagea: bet D&E, distorted Ring D
Glu-35 as acid, H+ to O of glycosidic bond
Carbonium cation stabilized by
1. -ve charge on Asp-52
2. half-chair formation of sugar D (strain) (resonance stabilize +charge on C-1 with O)


No comments yet. Add yours below!

Add a Comment

Your Comment

Please enter your name.

    Please enter your email address

      Please enter your Comment.

          Related Cheat Sheets

          oAuth End Points Cheat Sheet
          Object Oriented Design Cheat Sheet
          ISTQB Test Automation Engineering Cheat Sheet